678 related articles for article (PubMed ID: 37629202)
1. From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington's Disease Research.
Jiang A; Handley RR; Lehnert K; Snell RG
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629202
[TBL] [Abstract][Full Text] [Related]
2. Clinical Features of Huntington's Disease.
Ghosh R; Tabrizi SJ
Adv Exp Med Biol; 2018; 1049():1-28. PubMed ID: 29427096
[TBL] [Abstract][Full Text] [Related]
3. Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies.
Wright GEB; Black HF; Collins JA; Gall-Duncan T; Caron NS; Pearson CE; Hayden MR
Lancet Neurol; 2020 Nov; 19(11):930-939. PubMed ID: 33098802
[TBL] [Abstract][Full Text] [Related]
4. Investigations of Huntington's Disease and Huntington's Disease-Like Syndromes in Indian Choreatic Patients.
Kaur J; Parveen S; Shamim U; Sharma P; Suroliya V; Sonkar AK; Ahmad I; Garg J; Anand KS; Laskar S; Chowdhury D; Kushwaha S; Goyal V; Srivastava AK; Singh G; Faruq M
J Huntingtons Dis; 2020; 9(3):283-289. PubMed ID: 32675418
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease.
Bithell A; Johnson R; Buckley NJ
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1270-5. PubMed ID: 19909260
[TBL] [Abstract][Full Text] [Related]
6. Molecular Pathophysiological Mechanisms in Huntington's Disease.
Jurcau A
Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740453
[TBL] [Abstract][Full Text] [Related]
7. Aberrantly spliced HTT, a new player in Huntington's disease pathogenesis.
Gipson TA; Neueder A; Wexler NS; Bates GP; Housman D
RNA Biol; 2013 Nov; 10(11):1647-52. PubMed ID: 24256709
[TBL] [Abstract][Full Text] [Related]
8. Multiple clinical features of Huntington's disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration.
Podvin S; Reardon HT; Yin K; Mosier C; Hook V
J Neurol; 2019 Mar; 266(3):551-564. PubMed ID: 29956026
[TBL] [Abstract][Full Text] [Related]
9. Sirtuins as Modifiers of Huntington's Disease (HD) Pathology.
Neo SH; Tang BL
Prog Mol Biol Transl Sci; 2018; 154():105-145. PubMed ID: 29413175
[TBL] [Abstract][Full Text] [Related]
10. Huntington's disease: the past, present, and future search for disease modifiers.
Clabough EB
Yale J Biol Med; 2013 Jun; 86(2):217-33. PubMed ID: 23766742
[TBL] [Abstract][Full Text] [Related]
11. Huntington's Disease: Complex Pathogenesis and Therapeutic Strategies.
Tong H; Yang T; Xu S; Li X; Liu L; Zhou G; Yang S; Yin S; Li XJ; Li S
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612657
[TBL] [Abstract][Full Text] [Related]
12. Huntington's disease: from pathology and genetics to potential therapies.
Imarisio S; Carmichael J; Korolchuk V; Chen CW; Saiki S; Rose C; Krishna G; Davies JE; Ttofi E; Underwood BR; Rubinsztein DC
Biochem J; 2008 Jun; 412(2):191-209. PubMed ID: 18466116
[TBL] [Abstract][Full Text] [Related]
13. Huntington's disease: a clinical review.
McColgan P; Tabrizi SJ
Eur J Neurol; 2018 Jan; 25(1):24-34. PubMed ID: 28817209
[TBL] [Abstract][Full Text] [Related]
14. Update on Huntington's disease.
Berman SB; Greenamyre JT
Curr Neurol Neurosci Rep; 2006 Jul; 6(4):281-6. PubMed ID: 16822347
[TBL] [Abstract][Full Text] [Related]
15. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
[TBL] [Abstract][Full Text] [Related]
16. [Huntington's disease: clinical and molecular genetics].
Warita H; Shiro Y; Kashihara K; Abe K
Nihon Rinsho; 1999 Apr; 57(4):896-9. PubMed ID: 10222786
[TBL] [Abstract][Full Text] [Related]
17. Translating Antisense Technology into a Treatment for Huntington's Disease.
Lane RM; Smith A; Baumann T; Gleichmann M; Norris D; Bennett CF; Kordasiewicz H
Methods Mol Biol; 2018; 1780():497-523. PubMed ID: 29856033
[TBL] [Abstract][Full Text] [Related]
18. Huntington's disease: seeing the pathogenic process through a genetic lens.
Gusella JF; MacDonald ME
Trends Biochem Sci; 2006 Sep; 31(9):533-40. PubMed ID: 16829072
[TBL] [Abstract][Full Text] [Related]
19. Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels.
Rué L; Bañez-Coronel M; Creus-Muncunill J; Giralt A; Alcalá-Vida R; Mentxaka G; Kagerbauer B; Zomeño-Abellán MT; Aranda Z; Venturi V; Pérez-Navarro E; Estivill X; Martí E
J Clin Invest; 2016 Nov; 126(11):4319-4330. PubMed ID: 27721240
[TBL] [Abstract][Full Text] [Related]
20. Clinical Aspects of Huntington's Disease.
Ghosh R; Tabrizi SJ
Curr Top Behav Neurosci; 2015; 22():3-31. PubMed ID: 23975844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
